The traditional answer to a hard cold chain problem is to add mass — thicker walls, more ice. It works, but it’s a brute-force solution: heavier, bulkier, and expensive to freight, and it still struggles to hold tight sub-zero targets because thick walls don’t actually fix the rate of heat transfer, they just slow it down marginally. We wanted to solve the underlying physics instead of working around it.
A vacuum is one of the best insulators that exists, because there’s no medium left for heat to conduct or convect through. Cryophase’s VIP panels exploit that directly: a high-grade porous core, structurally similar to open-cell foam or silica aerogel, is laminated with multiple layers of non-porous aluminised polymer film to create a near-total vacuum. The result is an R-value of 36 — around twelve times that of standard polystyrene — achieved in a panel that’s thin rather than thick, because the vacuum is doing the insulating work, not the material’s bulk.
The engineering challenge with any vacuum panel is that its performance is fragile by nature — puncture it, and the vacuum collapses along with the R-value. We solved for that with multiple film layers for puncture resistance, a protective outer casing to absorb minor impacts, and a high-density polyurethane reinforcement layer for structural integrity, so the panel survives actual freight handling rather than just a controlled lab test. Paired with phase change material refrigerants, the finished shipper holds precise temperatures for over seven days, which removes the need for mid-route ice pack changes on most pharmaceutical logistics journeys. The flat-pack return design solves the last part of the lifecycle problem too — lower return freight cost and a smaller environmental footprint getting the packaging back into circulation.
It’s a materials-engineering answer to a logistics problem that more ice and thicker walls can’t actually solve efficiently — which is the kind of problem we built Cryophase to take on.